Belhaven Biopharma Initiates Pivotal Study of BBP01, a Nasal Powder Formulation of Epinephrine to Treat AnaphylaxisRandomized crossover trial will compare the pharmacokinetics and pharmacodynamics of intranasal epinephrine powder against intramuscular auto-injector and manual injection in healthy participants
